The Reality of Evaluating Urine Spot Sodium and Urine Spot Sodium Creatinine Ratio in Furosemide Stress Test as a New Biomarker in Diagnosing Progressive AKI in Critically Ill
Citation Information :
Chatterjee R, Gupta L. The Reality of Evaluating Urine Spot Sodium and Urine Spot Sodium Creatinine Ratio in Furosemide Stress Test as a New Biomarker in Diagnosing Progressive AKI in Critically Ill. Indian J Crit Care Med 2024; 28 (12):1089-1090.
Gameiro J, Fonseca JA, Outerelo C, Lopes JA. Acute kidney injury: From diagnosis to prevention and treatment strategies. J Clin Med 2020;9(6):1704. DOI: 10.3390/jcm9061704.
Suhas P, Anand RK, Baidya DK, Dehran M. Role of spot urine sodium in furosemide stress test in volume-overloaded critically ill patients with acute kidney injury. Indian J Crit Care Med 2024;28(12):1107–1111.
Bhosale SJ, Kulkarni AP. Biomarkers in acute kidney injury. Indian J Crit Care Med 2020(Suppl 3):S90–S93. DOI: 10.5005/jp-journals-10071-23398.
Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: A consensus statement. JAMA Netw Open 2020;3(10):e2019209. DOI: 10.1001/jamanetworkopen.2020.19209.
Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, et al. “Furosemide stress test and biomarkers for the prediction of AKI severity,” J Am Soc Nephrol 2015;26(8):2023–2031. DOI: 10.3410/f.725347402.793509694.
Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013;17(5):R207. DOI: 10.1186/cc13015.
Kulkarni AP, Bhosale SJ. “Epidemiology and pathogenesis of acute kidney injury in critically ill patients”. Indian J Crit Care Med 2020;24(Suppl 3):S84–S89. DOI: 10.5005/jp-journals-10071-23394.
Makris K, Spanou L. Acute kidney injury: Diagnostic approaches and controversies. Clin Biochem Rev 2016;37(4):153–175. PMID: 28167845.
Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anesthesia 2010;(65):283–293. DOI: 10.1111/j.1365-2044.2009.06228.x.
Zampieri FG, Bagshaw SM, Semler MW. Fluid therapy for critically ill adults with sepsis: A review. JAMA 2023;329(22):1967–1980. DOI: 10.1001/jama.2023.7560.
Besen BA, Gobatto AL, Melro LM, Maciel AT, Park M. Fluid and electrolyte overload in critically ill patients: An overview. World J Crit Care Med 2015;4(2):116–129. DOI: 10.5492/wjccm.v4.i2.116.
Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: Evaluation and management. BMC Nephrol 2016;17(1):109. DOI: 10.1186/s12882-016-0323-6.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease stevens. Kidney Int 105(4S):S117–S314. DOI: 10.1016/j.kint.2023.10.018.
Zazzeron L, Ottolina D, Scotti E, Ferrari M, Bruzzone P, Sibilla S, et al. Real-time urinary electrolyte monitoring after furosemide administration in surgical ICU patients with normal renal function. Ann Intensive Care 2016;6(1):72. DOI: 10.1186/s13613-016-0168-y.
